Tci Wealth Advisors, Inc. Rocket Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$7.96 - $16.64 $2,642 - $5,524	332 New	332 $5,000
Q4 2021 Jan 24, 2022	SELL	$21.52 - $36.02 $2,625 - $4,394	-122 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$27.42 - $48.97 $3,427 - $6,121	-125 Reduced 50.61%	122 $4,000
Q2 2021 Aug 02, 2021	BUY	$39.41 - $47.25 $7,330 - $8,788	186 Added 304.92%	247 $11,000
Q1 2021 Apr 29, 2021	BUY	$43.34 - $65.91 $2,643 - $4,020	61 New	61 $3,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.